BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

886 related articles for article (PubMed ID: 25589418)

  • 1. Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid.
    Alpsoy E; Akman-Karakas A; Uzun S
    Arch Dermatol Res; 2015 May; 307(4):291-8. PubMed ID: 25589418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study.
    Marazza G; Pham HC; Schärer L; Pedrazzetti PP; Hunziker T; Trüeb RM; Hohl D; Itin P; Lautenschlager S; Naldi L; Borradori L;
    Br J Dermatol; 2009 Oct; 161(4):861-8. PubMed ID: 19566661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pemphigus vulgaris is the most common autoimmune bullous disease in Northwestern Romania.
    Baican A; Baican C; Chiriac G; Chiriac MT; Macovei V; Zillikens D; Ciuce D; Sitaru C
    Int J Dermatol; 2010 Jul; 49(7):768-74. PubMed ID: 20618495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature.
    Sami N; Ahmed AR
    Dermatology; 2001; 202(4):293-301. PubMed ID: 11455140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of autoimmune bullous diseases in Middle Franconia.
    Sollfrank L; Schönfelder V; Sticherling M
    Front Immunol; 2023; 14():1256617. PubMed ID: 37881435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoimmune blistering diseases].
    Duvert-Lehembre S; Joly P
    Rev Med Interne; 2014 Mar; 35(3):166-73. PubMed ID: 23747156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of internal malignancies in autoimmune blistering diseases: pemphigus and bullous pemphigoid in Japan.
    Morioka S; Sakuma M; Ogawa H
    Dermatology; 1994; 189 Suppl 1():82-4. PubMed ID: 8049570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany.
    Bertram F; Bröcker EB; Zillikens D; Schmidt E
    J Dtsch Dermatol Ges; 2009 May; 7(5):434-40. PubMed ID: 19170813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence of internal malignancies in autoimmune bullous diseases.
    Iwashita K; Matsuyama T; Akasaka E; Mizutani K; Yamamoto K; Kondoh A; Nozawa M; Yagi Y; Ikoma N; Mabuchi T; Shinagawa H; Tamiya S; Nuruki H; Ohta Y; Umezawa Y; Ozawa A
    Tokai J Exp Clin Med; 2007 Mar; 32(1):42-7. PubMed ID: 21319056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bullous diseases in Malaysia: epidemiology and natural history.
    Adam BA
    Int J Dermatol; 1992 Jan; 31(1):42-5. PubMed ID: 1737688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of autoimmune bullous diseases in Kuwait.
    Nanda A; Dvorak R; Al-Saeed K; Al-Sabah H; Alsaleh QA
    Int J Dermatol; 2004 Dec; 43(12):876-81. PubMed ID: 15569006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid.
    Budimir J; Mihić LL; Situm M; Bulat V; Persić S; Tomljanović-Veselski M
    Acta Clin Croat; 2008 Mar; 47(1):13-8. PubMed ID: 18714642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of autoimmune bullous diseases in Iran: a 10-year review.
    Daneshpazhooh M; Chams-Davatchi C; Payandemehr P; Nassiri S; Valikhani M; Safai-Naraghi Z
    Int J Dermatol; 2012 Jan; 51(1):35-41. PubMed ID: 22182376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Autoimmune Bullous Diseases in Elderly Patients in Iran: A 10-Year Retrospective Study.
    Ghiasi M; Daneshpazhooh M; Ismonov M; Chams-Davatchi C
    Skinmed; 2017; 15(3):175-180. PubMed ID: 28705276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of IgA antibodies in pemphigus, bullous pemphigoid and mucous membrane pemphigoid.
    Cozzani E; Drosera M; Parodi A; Carrozzo M; Gandolfo S; Rebora A
    Acta Derm Venereol; 2004; 84(5):381-4. PubMed ID: 15370705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of bullous diseases in a Turkish university hospital: clinicoepidemiological characteristics and follow-up.
    Kutlubay Z; Sevim Keçici A; Çelik U; Mat MC
    Turk J Med Sci; 2021 Feb; 51(1):124-133. PubMed ID: 32892539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and classification of pemphigus and bullous pemphigoid.
    Kershenovich R; Hodak E; Mimouni D
    Autoimmun Rev; 2014; 13(4-5):477-81. PubMed ID: 24424192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worldwide epidemiologic factors in pemphigus vulgaris and bullous pemphigoid.
    Rosi-Schumacher M; Baker J; Waris J; Seiffert-Sinha K; Sinha AA
    Front Immunol; 2023; 14():1159351. PubMed ID: 37180132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study.
    Langan SM; Smeeth L; Hubbard R; Fleming KM; Smith CJ; West J
    BMJ; 2008 Jul; 337(7662):a180. PubMed ID: 18614511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.